Contact Us
  Search
The Business Research Company Logo
Global Allergy Diagnostics Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Allergy Diagnostics Market Report 2026

Global Outlook – By Test Type (In-Vivo Allergy Tests, In-Vitro Allergy Tests ), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens ), By Products (Consumables, Instruments ), By End User (Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes) - Market Size, Trends, And Global Forecast 2026-2035

Allergy Diagnostics Market Overview

• Allergy Diagnostics market size has reached to $6.99 billion in 2025 • Expected to grow to $13.03 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Surging Allergic Disease Cases Drive Growth In Allergy Diagnostics Market • Market Trend: Innovative AI-Powered Allergy Component Testing Platform Revolutionizes Allergy Diagnostics • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Allergy Diagnostics Market?

Allergy diagnostics involves tests and procedures to identify specific allergens, such as foods, pollens, or chemicals, triggering allergic reactions. Its main goal is to detect allergens accurately, allowing healthcare providers to suggest appropriate treatments. This improves the management of allergic conditions. The main types of allergy diagnostics tests are in-vivo allergy tests and in-vitro allergy tests. In-vivo allergy tests are performed on the human body to identify the cause of the allergic reaction. In-vitro allergy tests are performed in laboratories using test tubes and Petri dishes to identify the allergy-causing substance. The main products in allergy diagnostics include consumables, instruments, and luminometers. By allergens, the allergy diagnostics market is segmented into inhaled allergens, food allergens, and drug allergens. Major end-users of allergy diagnostics include diagnostic laboratories, hospital-based laboratories, and academic and research institutes.
Allergy Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Allergy Diagnostics Market Size and Share 2026?

The allergy diagnostics market size has grown rapidly in recent years. It will grow from $6.99 billion in 2025 to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing prevalence of allergies worldwide, adoption of skin prick and intradermal tests, expansion of hospital-based laboratories, growing awareness about allergy management, limited availability of advanced in-vitro kits.

What Is The Allergy Diagnostics Market Growth Forecast?

The allergy diagnostics market size is expected to see rapid growth in the next few years. It will grow to $13.03 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to advancement in component-resolved diagnostics, integration of automation in allergy testing, rising investment in research on novel allergens, growth of academic and diagnostic laboratories, increasing demand for personalized allergy treatment. Major trends in the forecast period include rising demand for accurate allergy diagnostics, growing adoption of in-vitro testing methods, expansion of food and drug allergen testing, increased use of elisa, rast, and crd kits, focus on rapid and point-of-care allergy detection.

Global Allergy Diagnostics Market Segmentation

1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests 2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens 3) By Products: Consumables, Instruments 4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes Subsegments: 1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests 2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

What Is The Driver Of The Allergy Diagnostics Market?

The increased occurrences of allergic diseases will propel the growth of the allergy diagnostics market. The rise in allergy diseases has been attributed to increased environmental pollution from traffic and numerous industries. An allergic reaction is described as an abnormal immune system response to an allergen. Allergy diseases include anaphylaxis, allergic rhinitis (often referred to as ‘hay fever’), food allergies, skin allergies, and allergic asthma. Avoiding the allergen is the most essential treatment for allergic disorders. As a result, proper allergy diagnosis is crucial for effective allergy treatment. For instance, in September 2024, according to Anaphylaxis UK, a UK-based charity, 20% of food allergy reactions occur at school. One in five children with food allergies experience bullying, while one in five parents report moderate-to-extreme anxiety. Nearly all parents of affected children exhibit post-traumatic stress symptoms (PTSS), with rates seven times higher among those whose children use adrenaline auto-injectors (AAIs). Thus, the rise in the prevalence of allergic diseases will further support the growth of the allergic diagnostics market.

Key Players In The Global Allergy Diagnostics Market

Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

What Are Latest Mergers And Acquisitions In The Allergy Diagnostics Market?

In July 2024, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx for an undisclosed amount. The acquisition of Roche seeks to strengthen Roche's diagnostics portfolio by incorporating LumiraDx's technologies, which will greatly enhance patient access to diagnostic testing, especially in primary care settings. LumiraDx is a US-based healthcare company provider of microfluidic immunofluorescence assays.

Regional Outlook

North America was the largest region in the allergy diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Allergy Diagnostics Market?

The allergy diagnostics market includes revenue earned by instruments such as immunoassay analyzers, ELISA analyzers, luminometers, and other instruments that are used to diagnose allergies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Allergy Diagnostics Market Report 2026?

The allergy diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the allergy diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Allergy Diagnostics Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$7.94 billion
Revenue Forecast In 2035$13.03 billion
Growth RateCAGR of 13.5% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredTest Type, Allergen, Products, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledbioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us